ObsEva: ObsEva Announces Delisting from SIX Swiss Exchange and Exemption from Certain Obligations Associated with the Maintenance of Listin

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland April 3, 2024 ObsEva SAÂ (SIX: OBSN), a biopharmaceutical company developing and commercializing novel...